大浪淘尽"伪白马" 医药股千亿阵营大换血-小产权房558

　　被暂停_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>上市_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>6个月后，*ST长生（00_blank class=infotextkey>get=_blank class=infotextkey>26_blank class=infotextkey>get=_blank class=infotextkey>80.SZ）_blank class=infotextkey>get=_blank class=infotextkey>即将_blank class=infotextkey>get=_blank class=infotextkey>迎来_blank class=infotextkey>get=_blank class=infotextkey>“_blank class=infotextkey>get=_blank class=infotextkey>退市_blank class=infotextkey>get=_blank class=infotextkey>判决_blank class=infotextkey>get=_blank class=infotextkey>”。根据*ST长生_blank class=infotextkey>get=_blank class=infotextkey>公告，9月15日暂停_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>上市_blank class=infotextkey>get=_blank class=infotextkey>到期后，_blank class=infotextkey>get=_blank class=infotextkey>深交所将在15个_blank class=infotextkey>get=_blank class=infotextkey>交易日内作出 _blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>公司_blank class=infotextkey>get=_blank class=infotextkey>股票是否_blank class=infotextkey>get=_blank class=infotextkey>终止_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>上市的_blank class=infotextkey>get=_blank class=infotextkey>决_blank class=infotextkey>定，_blank class=infotextkey>如果被_blank class=infotextkey>get=_blank class=infotextkey>终止_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>上市，_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>公司_blank class=infotextkey>get=_blank class=infotextkey>股票将_blank class=infotextkey>get=_blank class=infotextkey>进入_blank class=infotextkey>get=_blank class=infotextkey>退市整理期，_blank class=infotextkey>get=_blank class=infotextkey>交易_blank class=infotextkey>get=_blank class=infotextkey>期_blank class=infotextkey>get=_blank class=infotextkey>限为_blank class=infotextkey>30个_blank class=infotextkey>get=_blank class=infotextkey>交易日。

　　这或许是医药_blank class=infotextkey>get=_blank class=infotextkey>行业首个被_blank class=infotextkey>强制_blank class=infotextkey>get=_blank class=infotextkey>退市的_blank class=infotextkey>get=_blank class=infotextkey>案例，但从_blank class=infotextkey>get=_blank class=infotextkey>“白马_blank class=infotextkey>get=_blank class=infotextkey>”变成_blank class=infotextkey>get=_blank class=infotextkey>“黑天鹅_blank class=infotextkey>get=_blank class=infotextkey>”，*ST长生_blank class=infotextkey>不过是其_blank class=infotextkey>get=_blank class=infotextkey>中一例。_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>最_blank class=infotextkey>近一_blank class=infotextkey>get=_blank class=infotextkey>年来，医药_blank class=infotextkey>get=_blank class=infotextkey>行业_blank class=infotextkey>get=_blank class=infotextkey>“黑天鹅_blank class=infotextkey>get=_blank class=infotextkey>”_blank class=infotextkey>get=_blank class=infotextkey>事件_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>不断，_blank class=infotextkey>get=_blank class=infotextkey>成为_blank class=infotextkey>get=_blank class=infotextkey>高发雷区，_blank class=infotextkey>不_blank class=infotextkey>get=_blank class=infotextkey>少曾经_blank class=infotextkey>get=_blank class=infotextkey>风光的药企被资本无情抛弃。

　　_blank class=infotextkey>get=_blank class=infotextkey>有_blank class=infotextkey>get=_blank class=infotextkey>人沉沦，_blank class=infotextkey>get=_blank class=infotextkey>有_blank class=infotextkey>get=_blank class=infotextkey>人崛起。

　　在板块另一端，_blank class=infotextkey>恒瑞医药（_blank class=infotextkey>get=_blank class=infotextkey>600_blank class=infotextkey>get=_blank class=infotextkey>276.SH）、药明康德（_blank class=infotextkey>get=_blank class=infotextkey>60_blank class=infotextkey>3_blank class=infotextkey>get=_blank class=infotextkey>259.SH）、迈瑞_blank class=infotextkey>get=_blank class=infotextkey>医疗（_blank class=infotextkey>3007_blank class=infotextkey>get=_blank class=infotextkey>60.SZ）、爱尔眼科（_blank class=infotextkey>300015.SZ）等细分_blank class=infotextkey>get=_blank class=infotextkey>领域的_blank class=infotextkey>get=_blank class=infotextkey>龙_blank class=infotextkey>get=_blank class=infotextkey>头_blank class=infotextkey>get=_blank class=infotextkey>企业则在各路资本的热烈追捧_blank class=infotextkey>get=_blank class=infotextkey>下，_blank class=infotextkey>get=_blank class=infotextkey>股价_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>不断创_blank class=infotextkey>get=_blank class=infotextkey>下_blank class=infotextkey>get=_blank class=infotextkey>新_blank class=infotextkey>get=_blank class=infotextkey>高。截至_blank class=infotextkey>get=_blank class=infotextkey>2019年9月18日，总市值_blank class=infotextkey>get=_blank class=infotextkey>超过千_blank class=infotextkey>get=_blank class=infotextkey>亿元的医药_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>上市_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>公司已_blank class=infotextkey>get=_blank class=infotextkey>有_blank class=infotextkey>get=_blank class=infotextkey>6家。

　　_blank class=infotextkey>get=_blank class=infotextkey>“随着医_blank class=infotextkey>get=_blank class=infotextkey>保_blank class=infotextkey>get=_blank class=infotextkey>基_blank class=infotextkey>get=_blank class=infotextkey>金_blank class=infotextkey>get=_blank class=infotextkey>使用_blank class=infotextkey>get=_blank class=infotextkey>进入‘腾笼换鸟’的_blank class=infotextkey>get=_blank class=infotextkey>阶段，医药_blank class=infotextkey>get=_blank class=infotextkey>行业的_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>环境正在_blank class=infotextkey>get=_blank class=infotextkey>发生急剧_blank class=infotextkey>get=_blank class=infotextkey>变化。在_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>政策_blank class=infotextkey>get=_blank class=infotextkey>压力_blank class=infotextkey>get=_blank class=infotextkey>下，医药板块加速洗牌，内_blank class=infotextkey>部分化_blank class=infotextkey>get=_blank class=infotextkey>严_blank class=infotextkey>get=_blank class=infotextkey>重。_blank class=infotextkey>get=_blank class=infotextkey>那些_blank class=infotextkey>真正_blank class=infotextkey>get=_blank class=infotextkey>有_blank class=infotextkey>get=_blank class=infotextkey>创_blank class=infotextkey>get=_blank class=infotextkey>新能力和_blank class=infotextkey>get=_blank class=infotextkey>创_blank class=infotextkey>get=_blank class=infotextkey>新_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>布局的_blank class=infotextkey>get=_blank class=infotextkey>企业，在这一轮洗牌_blank class=infotextkey>get=_blank class=infotextkey>中脱颖而出。_blank class=infotextkey>get=_blank class=infotextkey>”9月18日，_blank class=infotextkey>get=_blank class=infotextkey>一位医药投行_blank class=infotextkey>get=_blank class=infotextkey>人士向_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>时_blank class=infotextkey>get=_blank class=infotextkey>代周报_blank class=infotextkey>get=_blank class=infotextkey>记者指出。

　　_blank class=infotextkey>get=_blank class=infotextkey>“伪白马_blank class=infotextkey>get=_blank class=infotextkey>”坠落

　　伪_blank class=infotextkey>get=_blank class=infotextkey>装被撕掉_blank class=infotextkey>get=_blank class=infotextkey>之前，*ST长生也算是医药板块一只白马股，_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>上市_blank class=infotextkey>get=_blank class=infotextkey>三年间，营_blank class=infotextkey>收和净利润_blank class=infotextkey>get=_blank class=infotextkey>增长_blank class=infotextkey>get=_blank class=infotextkey>又快_blank class=infotextkey>get=_blank class=infotextkey>又稳，_blank class=infotextkey>get=_blank class=infotextkey>现_blank class=infotextkey>get=_blank class=infotextkey>金_blank class=infotextkey>get=_blank class=infotextkey>流充沛。

　　_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>2018年_blank class=infotextkey>get=_blank class=infotextkey>7月_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>中旬，因_blank class=infotextkey>get=_blank class=infotextkey>疫苗_blank class=infotextkey>get=_blank class=infotextkey>造假_blank class=infotextkey>get=_blank class=infotextkey>事件_blank class=infotextkey>get=_blank class=infotextkey>东窗事发，*ST长生迅速坠落。_blank class=infotextkey>get=_blank class=infotextkey>事件_blank class=infotextkey>get=_blank class=infotextkey>发生后_blank class=infotextkey>不久，证监_blank class=infotextkey>get=_blank class=infotextkey>会_blank class=infotextkey>get=_blank class=infotextkey>发_blank class=infotextkey>get=_blank class=infotextkey>布《_blank class=infotextkey>get=_blank class=infotextkey>关于_blank class=infotextkey>get=_blank class=infotextkey>修_blank class=infotextkey>get=_blank class=infotextkey>改

　　证监_blank class=infotextkey>get=_blank class=infotextkey>会对_blank class=infotextkey>get=_blank class=infotextkey>退市_blank class=infotextkey>制度的这一_blank class=infotextkey>get=_blank class=infotextkey>修订，被外界_blank class=infotextkey>get=_blank class=infotextkey>广泛视_blank class=infotextkey>get=_blank class=infotextkey>作为*ST长生_blank class=infotextkey>get=_blank class=infotextkey>“量_blank class=infotextkey>get=_blank class=infotextkey>身_blank class=infotextkey>get=_blank class=infotextkey>打造_blank class=infotextkey>get=_blank class=infotextkey>”。从_blank class=infotextkey>get=_blank class=infotextkey>20_blank class=infotextkey>get=_blank class=infotextkey>1_blank class=infotextkey>get=_blank class=infotextkey>5年末借壳_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>上市，到_blank class=infotextkey>get=_blank class=infotextkey>2019年_blank class=infotextkey>3月被暂停_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>上市，_blank class=infotextkey>get=_blank class=infotextkey>再到或将_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>面临_blank class=infotextkey>强制_blank class=infotextkey>get=_blank class=infotextkey>退市，*ST长生在资本_blank class=infotextkey>get=_blank class=infotextkey>市场昙花一现，91_blank class=infotextkey>get=_blank class=infotextkey>亿元罚_blank class=infotextkey>get=_blank class=infotextkey>没款_blank class=infotextkey>get=_blank class=infotextkey>如何缴纳成谜。

　　另一只著名的医药_blank class=infotextkey>get=_blank class=infotextkey>“伪白马_blank class=infotextkey>get=_blank class=infotextkey>”亦在_blank class=infotextkey>get=_blank class=infotextkey>2019年轰然倒_blank class=infotextkey>get=_blank class=infotextkey>下。

　　顶着_blank class=infotextkey>get=_blank class=infotextkey>“_blank class=infotextkey>get=_blank class=infotextkey>中药饮片_blank class=infotextkey>get=_blank class=infotextkey>龙_blank class=infotextkey>get=_blank class=infotextkey>头_blank class=infotextkey>get=_blank class=infotextkey>”的名号，康美药业（ST康美，_blank class=infotextkey>get=_blank class=infotextkey>600518.SH）于_blank class=infotextkey>get=_blank class=infotextkey>20_blank class=infotextkey>get=_blank class=infotextkey>1_blank class=infotextkey>get=_blank class=infotextkey>5年4月_blank class=infotextkey>get=_blank class=infotextkey>成为A股_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>第一家市值_blank class=infotextkey>get=_blank class=infotextkey>突破千_blank class=infotextkey>get=_blank class=infotextkey>亿元的药企，在资本_blank class=infotextkey>get=_blank class=infotextkey>市场_blank class=infotextkey>get=_blank class=infotextkey>上_blank class=infotextkey>get=_blank class=infotextkey>风光无两。尽管外界质疑声_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>不断，其_blank class=infotextkey>get=_blank class=infotextkey>股价依旧岿然_blank class=infotextkey>不动。

　　直到_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>2018年_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>10月，康美药业的债券和_blank class=infotextkey>get=_blank class=infotextkey>股价莫名闪崩，其_blank class=infotextkey>get=_blank class=infotextkey>财务_blank class=infotextkey>get=_blank class=infotextkey>造假的_blank class=infotextkey>get=_blank class=infotextkey>行为才一点点_blank class=infotextkey>get=_blank class=infotextkey>暴露出来。_blank class=infotextkey>get=_blank class=infotextkey>2019年4月，康美药业_blank class=infotextkey>get=_blank class=infotextkey>发_blank class=infotextkey>get=_blank class=infotextkey>布_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>2018年年报_blank class=infotextkey>时_blank class=infotextkey>get=_blank class=infotextkey>突然_blank class=infotextkey>get=_blank class=infotextkey>“认错_blank class=infotextkey>get=_blank class=infotextkey>”：_blank class=infotextkey>get=_blank class=infotextkey>由于前期_blank class=infotextkey>get=_blank class=infotextkey>财务_blank class=infotextkey>get=_blank class=infotextkey>会计差错，_blank class=infotextkey>get=_blank class=infotextkey>造成_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>公司_blank class=infotextkey>get=_blank class=infotextkey>货币_blank class=infotextkey>get=_blank class=infotextkey>资_blank class=infotextkey>get=_blank class=infotextkey>金_blank class=infotextkey>get=_blank class=infotextkey>多计_blank class=infotextkey>get=_blank class=infotextkey>2_blank class=infotextkey>get=_blank class=infotextkey>99.44_blank class=infotextkey>get=_blank class=infotextkey>亿元，营业_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>收入_blank class=infotextkey>get=_blank class=infotextkey>多计88.98_blank class=infotextkey>get=_blank class=infotextkey>亿元等。康美药业在向_blank class=infotextkey>get=_blank class=infotextkey>投资者_blank class=infotextkey>get=_blank class=infotextkey>道歉_blank class=infotextkey>时仍坚称_blank class=infotextkey>get=_blank class=infotextkey>“_blank class=infotextkey>get=_blank class=infotextkey>财务差错_blank class=infotextkey>get=_blank class=infotextkey>”_blank class=infotextkey>_blank class=infotextkey>不是_blank class=infotextkey>get=_blank class=infotextkey>财务_blank class=infotextkey>get=_blank class=infotextkey>造假。

　　谎言终究_blank class=infotextkey>get=_blank class=infotextkey>会被戳破。

　　8月16日，证监_blank class=infotextkey>get=_blank class=infotextkey>会_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>公_blank class=infotextkey>get=_blank class=infotextkey>布_blank class=infotextkey>get=_blank class=infotextkey>调查结果_blank class=infotextkey>get=_blank class=infotextkey>显示，_blank class=infotextkey>get=_blank class=infotextkey>2016―_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>2018年期间，康美药业_blank class=infotextkey>get=_blank class=infotextkey>累计虚增营业_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>收入_blank class=infotextkey>get=_blank class=infotextkey>291._blank class=infotextkey>get=_blank class=infotextkey>28_blank class=infotextkey>get=_blank class=infotextkey>亿元，_blank class=infotextkey>get=_blank class=infotextkey>累计虚增营业利润_blank class=infotextkey>39._blank class=infotextkey>36_blank class=infotextkey>get=_blank class=infotextkey>亿元，_blank class=infotextkey>get=_blank class=infotextkey>累计_blank class=infotextkey>get=_blank class=infotextkey>多计利息_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>收入5.1_blank class=infotextkey>get=_blank class=infotextkey>亿元，_blank class=infotextkey>get=_blank class=infotextkey>累计虚增_blank class=infotextkey>get=_blank class=infotextkey>货币_blank class=infotextkey>get=_blank class=infotextkey>资_blank class=infotextkey>get=_blank class=infotextkey>金886_blank class=infotextkey>get=_blank class=infotextkey>亿元；_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>2018年年报虚增固_blank class=infotextkey>定_blank class=infotextkey>get=_blank class=infotextkey>资产、在建_blank class=infotextkey>get=_blank class=infotextkey>工程、_blank class=infotextkey>get=_blank class=infotextkey>投资性_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>房_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>地产_blank class=infotextkey>共计_blank class=infotextkey>36_blank class=infotextkey>get=_blank class=infotextkey>亿元；_blank class=infotextkey>get=_blank class=infotextkey>201_blank class=infotextkey>get=_blank class=infotextkey>6年、_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>2017年、_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>2018年均未按_blank class=infotextkey>get=_blank class=infotextkey>规_blank class=infotextkey>定披露_blank class=infotextkey>控股股_blank class=infotextkey>get=_blank class=infotextkey>东_blank class=infotextkey>get=_blank class=infotextkey>及其关_blank class=infotextkey>get=_blank class=infotextkey>联方非_blank class=infotextkey>get=_blank class=infotextkey>经营性占用_blank class=infotextkey>get=_blank class=infotextkey>资_blank class=infotextkey>get=_blank class=infotextkey>金的关_blank class=infotextkey>get=_blank class=infotextkey>联_blank class=infotextkey>get=_blank class=infotextkey>交易_blank class=infotextkey>get=_blank class=infotextkey>情况。

　　_blank class=infotextkey>get=_blank class=infotextkey>涉案_blank class=infotextkey>get=_blank class=infotextkey>金额创_blank class=infotextkey>get=_blank class=infotextkey>下A股_blank class=infotextkey>历史之_blank class=infotextkey>最。证监_blank class=infotextkey>get=_blank class=infotextkey>会认为，康美药业_blank class=infotextkey>get=_blank class=infotextkey>有预谋、_blank class=infotextkey>get=_blank class=infotextkey>有_blank class=infotextkey>get=_blank class=infotextkey>组织，_blank class=infotextkey>get=_blank class=infotextkey>长期、_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>系统实施_blank class=infotextkey>get=_blank class=infotextkey>财务_blank class=infotextkey>get=_blank class=infotextkey>造假_blank class=infotextkey>get=_blank class=infotextkey>行为，恶意欺骗_blank class=infotextkey>get=_blank class=infotextkey>投资者，_blank class=infotextkey>get=_blank class=infotextkey>影响极为恶劣，后果特别_blank class=infotextkey>get=_blank class=infotextkey>严_blank class=infotextkey>get=_blank class=infotextkey>重，_blank class=infotextkey>依法对康美药业及相关_blank class=infotextkey>get=_blank class=infotextkey>高管_blank class=infotextkey>get=_blank class=infotextkey>累计罚款595_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>万元，并对_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>上市_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>公司实际_blank class=infotextkey>get=_blank class=infotextkey>控制_blank class=infotextkey>get=_blank class=infotextkey>人等采取证券_blank class=infotextkey>get=_blank class=infotextkey>市场禁入措施。

　　虽然逃过_blank class=infotextkey>get=_blank class=infotextkey>退市一劫，康美药业的_blank class=infotextkey>get=_blank class=infotextkey>股价已经一落千丈，.fan_blank class=infotextkey>g558.com/pin_blank class=infotextkey>ghu/ tar_blank class=infotextkey>get=_blank class=infotextkey>平湖，市值蒸发_blank class=infotextkey>近_blank class=infotextkey>get=_blank class=infotextkey>八成。截至9月_blank class=infotextkey>get=_blank class=infotextkey>27日，其市值仅剩191.5_blank class=infotextkey>get=_blank class=infotextkey>亿元。

　　_blank class=infotextkey>get=_blank class=infotextkey>创_blank class=infotextkey>get=_blank class=infotextkey>新_blank class=infotextkey>get=_blank class=infotextkey>龙_blank class=infotextkey>get=_blank class=infotextkey>头崛起

　　.fan_blank class=infotextkey>g558.com/dalan_blank class=infotextkey>g/ tar_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>大浪淘沙始见_blank class=infotextkey>get=_blank class=infotextkey>金。

　　_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>时_blank class=infotextkey>get=_blank class=infotextkey>代周报_blank class=infotextkey>get=_blank class=infotextkey>记者_blank class=infotextkey>get=_blank class=infotextkey>注意到，自_blank class=infotextkey>get=_blank class=infotextkey>20_blank class=infotextkey>get=_blank class=infotextkey>1_blank class=infotextkey>get=_blank class=infotextkey>5年诞生_blank class=infotextkey>get=_blank class=infotextkey>首家千_blank class=infotextkey>get=_blank class=infotextkey>亿元市值药企后，到_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>2017年末和_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>2018年初，A股_blank class=infotextkey>get=_blank class=infotextkey>市场_blank class=infotextkey>get=_blank class=infotextkey>上已_blank class=infotextkey>get=_blank class=infotextkey>有_blank class=infotextkey>恒瑞医药、康美药业、_blank class=infotextkey>get=_blank class=infotextkey>云_blank class=infotextkey>get=_blank class=infotextkey>南白药、_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>上海莱士、华_blank class=infotextkey>get=_blank class=infotextkey>大基因、复_blank class=infotextkey>get=_blank class=infotextkey>星医药6只医药股的总市值_blank class=infotextkey>get=_blank class=infotextkey>超过千_blank class=infotextkey>get=_blank class=infotextkey>亿元_blank class=infotextkey>get=_blank class=infotextkey>规模。

　　_blank class=infotextkey>时隔_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>不到两年，_blank class=infotextkey>get=_blank class=infotextkey>有_blank class=infotextkey>get=_blank class=infotextkey>人掉队，也_blank class=infotextkey>get=_blank class=infotextkey>有_blank class=infotextkey>get=_blank class=infotextkey>人_blank class=infotextkey>get=_blank class=infotextkey>上位。

　　_blank class=infotextkey>恒瑞医药依旧稳坐_blank class=infotextkey>get=_blank class=infotextkey>“一哥_blank class=infotextkey>get=_blank class=infotextkey>”_blank class=infotextkey>get=_blank class=infotextkey>位置。自_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>2017年_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>11月起，_blank class=infotextkey>恒瑞医药市值_blank class=infotextkey>get=_blank class=infotextkey>一直_blank class=infotextkey>get=_blank class=infotextkey>保持在_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>2000_blank class=infotextkey>get=_blank class=infotextkey>亿元之_blank class=infotextkey>get=_blank class=infotextkey>上。_blank class=infotextkey>get=_blank class=infotextkey>2019年以来，其_blank class=infotextkey>get=_blank class=infotextkey>股价更是一路_blank class=infotextkey>get=_blank class=infotextkey>新_blank class=infotextkey>get=_blank class=infotextkey>高，截至9月_blank class=infotextkey>get=_blank class=infotextkey>27日_blank class=infotextkey>收盘，_blank class=infotextkey>恒瑞医药报81.05元/股，总市值达_blank class=infotextkey>3584.69_blank class=infotextkey>get=_blank class=infotextkey>亿元，是内_blank class=infotextkey>get=_blank class=infotextkey>地和_blank class=infotextkey>get=_blank class=infotextkey>香港资本_blank class=infotextkey>get=_blank class=infotextkey>市场_blank class=infotextkey>get=_blank class=infotextkey>上唯一一只市值_blank class=infotextkey>get=_blank class=infotextkey>超过_blank class=infotextkey>3000_blank class=infotextkey>get=_blank class=infotextkey>亿元的医药股。

　　从业绩来看，_blank class=infotextkey>get=_blank class=infotextkey>2019年_blank class=infotextkey>get=_blank class=infotextkey>上_blank class=infotextkey>get=_blank class=infotextkey>半年，_blank class=infotextkey>恒瑞医药_blank class=infotextkey>get=_blank class=infotextkey>实现营_blank class=infotextkey>收_blank class=infotextkey>get=_blank class=infotextkey>100._blank class=infotextkey>get=_blank class=infotextkey>26_blank class=infotextkey>get=_blank class=infotextkey>亿元，同比_blank class=infotextkey>get=_blank class=infotextkey>增长_blank class=infotextkey>get=_blank class=infotextkey>29.19%；归母净利润_blank class=infotextkey>get=_blank class=infotextkey>24.1_blank class=infotextkey>get=_blank class=infotextkey>2_blank class=infotextkey>get=_blank class=infotextkey>亿元，同比_blank class=infotextkey>get=_blank class=infotextkey>增长_blank class=infotextkey>get=_blank class=infotextkey>26._blank class=infotextkey>3_blank class=infotextkey>get=_blank class=infotextkey>2%。

　　除_blank class=infotextkey>恒瑞医药之外，前述_blank class=infotextkey>get=_blank class=infotextkey>其他5家医药_blank class=infotextkey>get=_blank class=infotextkey>企业的总市值都已跌出千_blank class=infotextkey>get=_blank class=infotextkey>亿元阵营。截至9月_blank class=infotextkey>get=_blank class=infotextkey>27日，_blank class=infotextkey>get=_blank class=infotextkey>云_blank class=infotextkey>get=_blank class=infotextkey>南白药和复_blank class=infotextkey>get=_blank class=infotextkey>星医药的总市值分别为976.70_blank class=infotextkey>get=_blank class=infotextkey>亿元和 646._blank class=infotextkey>11_blank class=infotextkey>get=_blank class=infotextkey>亿元；_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>上海莱士、华_blank class=infotextkey>get=_blank class=infotextkey>大基因都已跌落神坛，市值缩水_blank class=infotextkey>get=_blank class=infotextkey>大半，仅剩_blank class=infotextkey>get=_blank class=infotextkey>下_blank class=infotextkey>390.01_blank class=infotextkey>get=_blank class=infotextkey>亿元、_blank class=infotextkey>get=_blank class=infotextkey>257.46_blank class=infotextkey>get=_blank class=infotextkey>亿元。

　　而从美股转_blank class=infotextkey>get=_blank class=infotextkey>回A股的迈瑞_blank class=infotextkey>get=_blank class=infotextkey>医疗、药明康德_blank class=infotextkey>以及_blank class=infotextkey>get=_blank class=infotextkey>医疗_blank class=infotextkey>get=_blank class=infotextkey>服务_blank class=infotextkey>get=_blank class=infotextkey>龙_blank class=infotextkey>get=_blank class=infotextkey>头爱尔眼科后来居_blank class=infotextkey>get=_blank class=infotextkey>上，_blank class=infotextkey>get=_blank class=infotextkey>成功_blank class=infotextkey>get=_blank class=infotextkey>进入千_blank class=infotextkey>get=_blank class=infotextkey>亿元阵营。截至9月_blank class=infotextkey>get=_blank class=infotextkey>27日_blank class=infotextkey>收盘，迈瑞_blank class=infotextkey>get=_blank class=infotextkey>医疗、药明康德、爱尔眼科的市值分别达_blank class=infotextkey>get=_blank class=infotextkey>2_blank class=infotextkey>307.87_blank class=infotextkey>get=_blank class=infotextkey>亿元、14_blank class=infotextkey>get=_blank class=infotextkey>25.46_blank class=infotextkey>get=_blank class=infotextkey>亿元和_blank class=infotextkey>get=_blank class=infotextkey>1089.19_blank class=infotextkey>get=_blank class=infotextkey>亿元。

　　另外，在_blank class=infotextkey>get=_blank class=infotextkey>香港_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>上市的_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>中国生物制药（0_blank class=infotextkey>1177.HK）、翰森制药（0_blank class=infotextkey>369_blank class=infotextkey>get=_blank class=infotextkey>2.HK）的市值亦冲_blank class=infotextkey>get=_blank class=infotextkey>到了1_blank class=infotextkey>get=_blank class=infotextkey>26_blank class=infotextkey>3.87亿_blank class=infotextkey>港元和_blank class=infotextkey>get=_blank class=infotextkey>1_blank class=infotextkey>345.85亿_blank class=infotextkey>港元。

　　医药_blank class=infotextkey>get=_blank class=infotextkey>行业的千_blank class=infotextkey>get=_blank class=infotextkey>亿元阵营_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>不断更迭，其_blank class=infotextkey>get=_blank class=infotextkey>背后映射的正是_blank class=infotextkey>get=_blank class=infotextkey>行业_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>不断洗牌、资本_blank class=infotextkey>get=_blank class=infotextkey>投资_blank class=infotextkey>get=_blank class=infotextkey>风向切换的结果。

　　_blank class=infotextkey>get=_blank class=infotextkey>“_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>get=_blank class=infotextkey>中国医药_blank class=infotextkey>get=_blank class=infotextkey>产业站在_blank class=infotextkey>get=_blank class=infotextkey>转型的_blank class=infotextkey>get=_blank class=infotextkey>十字_blank class=infotextkey>get=_blank class=infotextkey>路口，_blank class=infotextkey>get=_blank class=infotextkey>未来_blank class=infotextkey>get=_blank class=infotextkey>突破的唯一路径_blank class=infotextkey>get=_blank class=infotextkey>就是_blank class=infotextkey>get=_blank class=infotextkey>创_blank class=infotextkey>get=_blank class=infotextkey>新。_blank class=infotextkey>get=_blank class=infotextkey>可以看到，当前_blank class=infotextkey>get=_blank class=infotextkey>无论是医_blank class=infotextkey>get=_blank class=infotextkey>保_blank class=infotextkey>get=_blank class=infotextkey>还是药品审评审批，_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>政策都在向_blank class=infotextkey>get=_blank class=infotextkey>创_blank class=infotextkey>get=_blank class=infotextkey>新药倾斜。_blank class=infotextkey>get=_blank class=infotextkey>”前述医药投行_blank class=infotextkey>get=_blank class=infotextkey>人士向_blank class=infotextkey>get=_blank class=infotextkey>_blank class=infotextkey>时_blank class=infotextkey>get=_blank class=infotextkey>代周报_blank class=infotextkey>get=_blank class=infotextkey>记者_blank class=infotextkey>get=_blank class=infotextkey>表示，_blank class=infotextkey>get=_blank class=infotextkey>“资本在向_blank class=infotextkey>get=_blank class=infotextkey>创_blank class=infotextkey>get=_blank class=infotextkey>新性、确_blank class=infotextkey>定性更_blank class=infotextkey>get=_blank class=infotextkey>强的_blank class=infotextkey>get=_blank class=infotextkey>头_blank class=infotextkey>部_blank class=infotextkey>get=_blank class=infotextkey>企业聚拢，.fan_blank class=infotextkey>g558.com/xixian_blank class=infotextkey>g/ tar_blank class=infotextkey>get=_blank class=infotextkey>西乡，形成强者_blank class=infotextkey>恒_blank class=infotextkey>get=_blank class=infotextkey>强的_blank class=infotextkey>get=_blank class=infotextkey>趋势。_blank class=infotextkey>get=_blank class=infotextkey>那些_blank class=infotextkey>真正的_blank class=infotextkey>get=_blank class=infotextkey>创_blank class=infotextkey>get=_blank class=infotextkey>新_blank class=infotextkey>get=_blank class=infotextkey>得到了_blank class=infotextkey>get=_blank class=infotextkey>市场的嘉奖。_blank class=infotextkey>get=_blank class=infotextkey>”